Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Toby Zidle who wrote (1546)	12/20/1998 10:18:00 PM
From: William Whitehead Jr.	Respond to of 2173

I've learned over the years that anything is possible with these small developing biotechs. Not to long ago HYAL was given up for dead and the stock was all the way down to 35 cents. Friday it closed a near a buck. Not a bad return for a couple of months. The potential for a new 'partner' or other White Knight makes these companies an interesting speculation. Whitey,

To: Toby Zidle who wrote (1546)	12/22/1998 4:51:00 PM
From: LLCF	Read Replies (1) \| Respond to of 2173

<The closing price Friday on AMLM was 50 cents Asked. If you bought it at Friday's close, you can't possibly lose more than 50 cents a share. On the other hand, AMLN can get favorable test results, a new sponsor, a buyout, a new drug announcement, even just a bottoming out and reversal of the price trend. What's your upside target? $2-$3 in a year? What are your odds? 25 percent? (0.25 * 2) + (0.75 * 0) = 50 cents. A wash. (0.25 * 3) + (0.75 * 0) = 75 cents. A Buy with 50% appreciation. Even if it takes 12 months to get there, it makes a very nice annual return. > I like you're thinking... DAK